Sep 1, 2026 09:07AM
Dec 21, 2025 04:00AM
Nov 12, 2025 10:00AM
Nov 6, 2025 04:30PM
Aug 7, 2025 04:30PM
Jul 22, 2025 08:02AM
Jul 22, 2025 08:00AM Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
Mar 15, 2025 06:40PM
Dec 10, 2024 08:00AM
Nov 13, 2024 04:30PM
Nov 1, 2024 08:00AM
Sep 14, 2024 03:00AM
Aug 22, 2024 08:04AM
Aug 22, 2024 08:00AM Sutro Biopharma Announces Initiation of REFRĪ±ME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer
May 13, 2024 04:30PM
Apr 30, 2024 08:00AM
Jan 4, 2024 04:05PM
Dec 14, 2023 04:05PM
Dec 11, 2023 04:05PM
Dec 11, 2023 04:05PM
Nov 13, 2023 04:30PM Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
May 15, 2023 08:00AM
Mar 30, 2023 04:30PM
Jan 9, 2023 04:05PM
Jan 9, 2023 04:05PM
Dec 10, 2022 10:30AM
Nov 8, 2022 04:30PM
Aug 8, 2022 04:30PM Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
Jun 28, 2022 09:11AM
Jun 3, 2022 04:01PM
Jun 2, 2022 07:00AM
May 9, 2022 04:30PM
Apr 29, 2022 05:00PM
Apr 8, 2022 01:00PM
Apr 5, 2022 07:00AM Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 30, 2022 04:05PM
Mar 3, 2022 07:00AM
Feb 28, 2022 04:35PM
Jan 6, 2022 07:00AM
Jan 5, 2022 04:32PM
Jan 5, 2022 04:30PM
Dec 27, 2021 07:02AM Sutro Biopharma Inc. (STRO) and Tasly Biopharmaceuticals Announce Exclusive License Agreement for STRO-002 in Greater China
Dec 27, 2021 07:00AM
Dec 27, 2021 07:00AM
Dec 13, 2021 07:00AM
Nov 22, 2021 07:00AM
Nov 17, 2021 07:02AM
Nov 17, 2021 07:00AM
Nov 10, 2021 07:00AM Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
Nov 2, 2021 07:00AM

329,886 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All